PTPRN2 encodes a protein tyrosine phosphatase receptor that lacks canonical phosphatase activity but plays critical roles in neuroendocrine function and vesicle-mediated secretion 1. Despite evolutionary loss of tyrosine phosphatase activity due to mutations in catalytic domains, PTPRN2 has acquired essential functions in insulin secretion, neurotransmitter regulation, and hormone release 1. The protein is essential for maintaining insulin-containing vesicles and glucose-stimulated insulin secretion in pancreatic β-cells 2. PTPRN2 demonstrates significant disease relevance across multiple conditions. In Parkinson's disease, it shows differential DNA methylation patterns in brain tissue, suggesting epigenetic regulation in neurodegeneration 3. The gene is implicated in diabetes susceptibility through transgenerational inheritance mechanisms involving DNA methylation changes that affect insulin secretion pathways 2. PTPRN2 expression is also associated with male fertility, being downregulated in heavy smokers with reduced sperm quality 4. Additionally, splicing variants in PTPRN2 have been identified in amyotrophic lateral sclerosis patients 5. The protein appears as a primary autoantigen in autoimmune diseases, potentially due to somatic mutations in its simple tandem repeat sequences 6. These findings establish PTPRN2 as a multifunctional protein critical for neuroendocrine regulation with broad implications for metabolic and neurological disorders.